Federal Judge Allows Eli Lilly’s Trademark Infringement and False Advertising Claims to Proceed in Seattle Clinic Case

A federal judge in Washington has ruled on Eli Lilly’s lawsuit against two Seattle-area clinics and the associated doctors. The lawsuit accuses the clinics of misleading consumers to buy unauthorized versions of the company’s diabetes and weight loss drugs, Mounjaro and Zepbound. While the court dismissed Eli Lilly’s consumer protection claim, it preserved the allegations of trademark infringement and false advertising. These legal proceedings are part of Eli Lilly’s efforts to protect its intellectual property and market position in the pharmaceutical industry. For more details, visit the full article on Law360.